-
November 1, 2008
A closely watched hepatitis C treatment being developed by Vertex Pharmaceuticals Inc showed an impressive ability to knock out the virus in patients who failed other treatments and those not previously treated for the serious liver disease, data from mid-stage studies show.
-
January 25, 2012
U.S. hepatitis A vaccine rates vary widely
NEW YORK (Reuters Health) - Although about 85 percent of kids in two U.S. states have had a complete set of hepatitis A vaccines, overall just three in 10 have had both shots, according to a new survey from the Centers for Disease Control and Prevention (CDC).
-
January 25, 2012
Device makers urge coverage of weight-loss surgery
CHICAGO (Reuters) - Device manufacturers are pushing the U.S. government and health insurers to cover weight-loss surgery, an effort that could give millions more obese Americans access to the treatments.
-
January 24, 2012
Arsenic cancer risk still high decades later
NEW YORK (Reuters Health) - People exposed to very high levels of arsenic in Chilean drinking water back in the 1950s and 60s are still showing a higher-than-normal risk of bladder cancer -- years after the arsenic problem was brought under control, a new study shows.
-
January 23, 2012
Korean research, a first step toward Dr. Smartphone?
SEOUL (Reuters) - Tired of long waits at the hospital for medical tests? If Korean researchers have their way, your smartphone could one day eliminate that -- and perhaps even tell you that you have cancer.
-
January 18, 2012
FDA approves BTG's drug for cancer toxicity
WASHINGTON (Reuters) - U.S. health regulators gave the nod on Tuesday to a drug from British specialty drugmaker BTG Plc that helps cancer patients get rid of toxic levels of a chemotherapy treatment.
-
January 16, 2012
China cancer village tests law against pollution
XIAOXIN, China (Reuters) - Nothing in Wu Wenyong's rural childhood hinted he would end up on a hospital bed aged 15, battling two kinds of cancer.
-
January 12, 2012
Sugary soda ups risky fat deposits
NEW YORK (Reuters Health) - Drinking a liter of regular cola every day increases the amount of fat in the liver and in the muscles and surrounding the organs in the belly, according to a new Danish study.
-
January 12, 2012
Murder knocked off list of top U.S. killers: CDC
CHICAGO (Reuters) - A respiratory illness that strikes the elderly knocked homicide off the list of the top killers in the United States for the first time in 45 years in 2010, the Centers for Disease Control and Prevention said on Wednesday.
-
January 10, 2012
Most toddler vaccines not linked to blood disease
NEW YORK (Reuters Health) - Although the MMR vaccine has been linked to a heightened risk of a rare blood disorder, other childhood vaccines do not appear to be, researchers reported Monday.
-
January 10, 2012
New DNA reader to bring genetics to clinics
NEW YORK (Reuters) - A new DNA reader could bring genetics to medical clinics.
-
January 9, 2012
Statin use tied to more diabetes in women
NEW YORK (Reuters Health) - Cholesterol-lowering drugs may be linked to an increased risk of diabetes, according to a new study of middle-aged and older women.
-
January 5, 2012
Cancer rates in U.S. keep falling: report
-
January 4, 2012
Experimental hep C vaccine shows early promise
LONDON (Reuters) - A new vaccine against the chronic liver disease hepatitis C has shown promising results in an early-stage clinical trial in humans, British and Italian scientists said on Wednesday.
-
January 4, 2012
Higher alcohol prices may curb drinking: study
NEW YORK (Reuters Health) - A new Canadian study suggests increasing the minimum price of beer, liquor and other alcoholic beverages may reduce how much people drink.
-
December 30, 2011
Chinese city finds cancer-causing fungi in food
SHANGHAI (Reuters) - Chinese food safety regulators in the southern city of Shenzhen have found carcinogenic mildew in peanuts and cooking oil, the official Xinhua news agency reported on Friday.
-
December 29, 2011
Statins tied to lower risk of fatal prostate cancer
NEW YORK (Reuters Health) - In a new study of middle-aged New Jersey men, taking cholesterol-lowering drugs was linked to a lower chance of dying from prostate cancer.
-
December 26, 2011
China's Mengniu says destroys tainted milk
SHANGHAI (Reuters) - China Mengniu Dairy Co Ltd, the nation's biggest dairy firm, said it had destroyed milk found to be contaminated with a cancer-causing substance, the latest food safety problem to hit the country's dairy industry.
-
December 23, 2011
Leukemia patients at greatest risk of listeriosis
NEW YORK (Reuters Health) - People with certain conditions, including leukemia, other cancers and pregnancy, are at the greatest risk of getting sick from the food-borne bacterium Listeria, French researchers report in a new study.
-
December 20, 2011
Experimental malaria vaccine shows early promise
LONDON (Reuters) - British scientists have developed an experimental malaria vaccine that may have the potential to neutralize all strains of the most deadly species of malaria parasite.
-
December 20, 2011
CA sperm donor at odds with federal regulators
OAKLAND, Calif. (Reuters) - An electronics company engineer who the U.S. government considers a one-man sperm bank has fathered an estimated 14 children through free donations of his semen that he advertises over the Internet.
-
December 15, 2011
Chimp research rarely warranted: U.S. expert panel
CHICAGO (Reuters) - Use of chimpanzees in government-funded medical research should be strictly limited, reserved only for studies where no suitable alternative is available or where testing in people would be unethical, a U.S. expert panel said on Thursday.
-
December 13, 2011
Experimental diet drug keeps weight off for 2 years
NEW YORK (Reuters Health) - An experimental diet drug seems to help some obese people shed pounds, and keep them off for two years, researchers report.
-
December 12, 2011
Gene therapy proves effective for hemophilia B
SAN DIEGO (Reuters) - A single treatment with gene therapy, an experimental technique for fixing faulty genes, has been shown to boost output of a vital blood clotting factor, possibly offering a long-term solution for people with hemophilia B.
-
December 5, 2011
Pfizer cancer drug effect may be limited-FDA staff
Dec 5 (Reuters) - Slower tumor growth in kidney cancer patients taking Pfizer Inc's experimental drug, Inlyta, in a clinical trial was driven by a subset of patients who are rare in the United States, U.S. Food and Drug Administration researchers said.
-
December 5, 2011
Map study finds vivax malaria has firm grip in Asia
LONDON (Reuters) - Progress is being made in the fight against the most common form of malaria in Africa, but a long-lasting type of the mosquito-borne parasitic disease has a tight grip on swathes of South Asia and parts of Latin America, scientists said Monday.
-
November 29, 2011
Babies sleep better following afternoon vaccines
NEW YORK (Reuters Health) - Two-month-old babies who receive immunizations in the afternoon sleep better afterward than children who have their shots in the morning, according to a new study.
-
November 27, 2011
Many parents request delays in vaccine schedule
NEW YORK (Reuters Health) - More than three quarters of pediatricians said they sometimes or often get asked by parents to use an "alternative" vaccination schedule that strays from national recommendations, according to a new survey of Washington State doctors.
-
November 25, 2011
Robin Gibb says "on road to recovery"
LOS ANGELES (Reuters) - Singer Robin Gibb of the Bee Gees Wednesday said he is on the road to recovery after being "very unwell" in recent days, and he thanked fans for their support in a message posted on his website.
-
November 23, 2011
Choline-rich diet tied to sharper memory
NEW YORK (Reuters Health) - People who get plenty of choline in their diets may perform better on memory tests, and be less likely to show brain changes associated with dementia, a new study suggests.
-
November 23, 2011
Cholesterol drugs safe, even after a decade of use
LONDON (Reuters) - Cholesterol-lowering drugs continue to produce benefits without any serious safety problems, such as increased cancer risk, even after more than a decade of use, researchers said on Wednesday.
-
October 28, 2011
Would-be fat-fighter Hoodia nothing but side effects
NEW YORK (Reuters Health) - A new Unilever report reveals why the consumer goods giant chose to pull the plug on the alleged fat-fighting supplement Hoodia after spending a reported $25 million developing it.
-
October 28, 2011
Heavy drinking tied to higher stomach cancer risk
NEW YORK (Reuters Health) - Men who down more than four alcoholic drinks in a day may have a heightened risk of stomach cancer, a large European analysis suggests.
-
October 26, 2011
REFILE: Report links HPV with heart attacks, strokes
NEW YORK (Reuters Health) - A new study shows heart attacks and strokes are more common in women infected with human papillomavirus, or HPV.
-
October 26, 2011
Reports links HPV with heart attacks, strokes
NEW YORK (Reuters Health) - A new study shows heart attacks and strokes are more common in women infected with human papillomavirus, or HPV.
-
October 25, 2011
US advisers recommend diabetics get Hep B vaccine
-
October 24, 2011
Shunning water linked to high blood sugar
NEW YORK (Reuters Health) - People who drink less than a couple of glasses of water each day may be more likely to develop abnormally high blood sugar, a new study suggests.
-
October 21, 2011
More people poisoned by wild mushrooms in Northeast
LITTLETON, New Hampshire (Reuters) - It has been a banner year for wild mushrooms in the Northeast, thanks to Hurricane Irene and heavy autumn rains. While that has delighted foragers, it has also led to a surge in poisonings.
-
October 20, 2011
More breast cancer diagnosed in women with diabetes
NEW YORK (Reuters Health) - Women with recently diagnosed diabetes may be more likely to also get a breast cancer diagnosis than those without diabetes, suggests a new study from Canada.
-
October 20, 2011
Jackson got more sedative than doc admits: expert
LOS ANGELES (Reuters) - Michael Jackson had more of the sedative lorazepam in his blood stream than his doctor admitted giving him on the day he died, a top anesthesiology expert testified on Thursday.
-
October 20, 2011
Mosquito lab has "world's most dangerous animals"
SEATTLE (Reuters) - He keeps them in warm, comfortable bug dorms, feeds them on meals of human blood with the occasional sugar water snack and lives in awe of their killing power.
-
October 18, 2011
Malaria scientist celebrates success after 24 years
SEATTLE (Reuters) - For Joe Cohen, a GlaxoSmithKline research scientist who has spent 24 years trying to create the world's first malaria vaccine, Tuesday, October 18, 2011 goes down as a fabulous day.
-
October 18, 2011
World's first malaria vaccine works in major trial
SEATTLE/LONDON (Reuters) - An experimental vaccine from GlaxoSmithKline halved the risk of African children getting malaria in a major clinical trial, making it likely to become the world's first shot against the deadly disease.
-
October 18, 2011
Male breast cancer rare, but can be aggressive
NEW YORK (Reuters Health) - Men get diagnosed with breast cancer at less than one percent the rate of women, according to a new analysis of cancer rates from six cities and countries.
-
October 12, 2011
New stem cell method makes functioning liver cells
LONDON (Reuters) - British scientists have developed a new stem cell technique for growing working liver cells which could eventually avoid the need for costly and risky liver transplants.
-
October 6, 2011
Dozens of states probe Medco/Express Scripts deal
WASHINGTON (Reuters) - Over two dozen states are scrutinizing Express Scripts' proposed acquisition of Medco Health Solutions, as pharmacists stoke fears that the $22 billion deal would propel the companies' aggressive tactics.
-
October 4, 2011
Higher testosterone tied to lower heart risks
NEW YORK (Reuters Health) - Elderly men with naturally higher levels of testosterone may be less likely to suffer a heart attack or stroke than those with lower levels of the hormone, a new study finds.
-
October 3, 2011
Behavioral therapies work for weight loss: review
NEW YORK (Reuters Health) - Diet changes, exercise and other behavioral tactics do help obese adults shed some pounds -- with or without the help of medication, according to a study published Monday.
-
October 2, 2011
Parents delaying, skipping recommended vaccines
NEW YORK (Reuters Health) - More than one in ten parents uses an "alternative" vaccination schedule for their young children, including refusing vaccines altogether, according to a U.S. survey.
-
September 30, 2011
Alabama organ center officials in plea deal
BIRMINGHAM, Ala (Reuters) - Former directors from one of the first organ transplant centers in the United States agreed on Thursday to plead guilty to health care and mail fraud over a kickbacks scheme, officials said.
-
September 29, 2011
Vertex takes early rounds of hep C bout with Merck